Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$67.99M
↑ 187% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-78.57M
Historical baseline
PeriodValueYoY Change
2025$67.99M+267.2%
2024$-40.66M-73.9%
2023$-23.38M+68.0%
2022$-73.15M+71.1%
2021$-252.97M-129.2%
2020$-110.39M+57.1%
2019$-257.44M-164.1%
2018$-97.49M-73.6%
2017$-56.16M-197.0%
2016$57.91M-